BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33876292)

  • 1. Erythroleukemia: an Update.
    Weinberg OK; Arber DA
    Curr Oncol Rep; 2021 Apr; 23(6):69. PubMed ID: 33876292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute erythroid leukemia.
    Zuo Z; Polski JM; Kasyan A; Medeiros LJ
    Arch Pathol Lab Med; 2010 Sep; 134(9):1261-70. PubMed ID: 20807044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shifting of erythroleukemia to myelodysplastic syndrome according to the revised WHO classification: Biologic and cytogenetic features of shifted erythroleukemia.
    Ryu S; Park HS; Kim SM; Im K; Kim JA; Hwang SM; Yoon SS; Lee DS
    Leuk Res; 2018 Jul; 70():13-19. PubMed ID: 29729583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To bi or not to bi: Acute erythroid leukemias and hematopoietic lineage choice.
    Di Genua C; Nerlov C
    Exp Hematol; 2021 May; 97():6-13. PubMed ID: 33600869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular pathogenesis and therapeutic targets in acute erythroid leukemia].
    Takeda J
    Rinsho Ketsueki; 2022; 63(2):121-133. PubMed ID: 35264503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythroleukemia-historical perspectives and recent advances in diagnosis and management.
    Boddu P; Benton CB; Wang W; Borthakur G; Khoury JD; Pemmaraju N
    Blood Rev; 2018 Mar; 32(2):96-105. PubMed ID: 28965757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers.
    Fagnan A; Bagger FO; Piqué-Borràs MR; Ignacimouttou C; Caulier A; Lopez CK; Robert E; Uzan B; Gelsi-Boyer V; Aid Z; Thirant C; Moll U; Tauchmann S; Kurtovic-Kozaric A; Maciejewski J; Dierks C; Spinelli O; Salmoiraghi S; Pabst T; Shimoda K; Deleuze V; Lapillonne H; Sweeney C; De Mas V; Leite B; Kadri Z; Malinge S; de Botton S; Micol JB; Kile B; Carmichael CL; Iacobucci I; Mullighan CG; Carroll M; Valent P; Bernard OA; Delabesse E; Vyas P; Birnbaum D; Anguita E; Garçon L; Soler E; Schwaller J; Mercher T
    Blood; 2020 Aug; 136(6):698-714. PubMed ID: 32350520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A History and Current Understanding of Acute Erythroid Leukemia.
    Alexander C
    Clin Lymphoma Myeloma Leuk; 2023 Aug; 23(8):583-588. PubMed ID: 37246017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of 97 previously diagnosed de novo adult acute erythroid leukemia patients following the 2016 revision to World Health Organization classification.
    Qiu S; Jiang E; Wei H; Lin D; Zhang G; Wei S; Zhou C; Liu K; Wang Y; Liu B; Liu Y; Gong B; Gong X; Feng S; Mi Y; Han M; Wang J
    BMC Cancer; 2017 Aug; 17(1):534. PubMed ID: 28793875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
    Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
    Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia.
    Takeda J; Yoshida K; Nakagawa MM; Nannya Y; Yoda A; Saiki R; Ochi Y; Zhao L; Okuda R; Qi X; Mori T; Kon A; Chiba K; Tanaka H; Shiraishi Y; Kuo MC; Kerr CM; Nagata Y; Morishita D; Hiramoto N; Hangaishi A; Nakazawa H; Ishiyama K; Miyano S; Chiba S; Miyazaki Y; Kitano T; Usuki K; Sezaki N; Tsurumi H; Miyawaki S; Maciejewski JP; Ishikawa T; Ohyashiki K; Ganser A; Heuser M; Thol F; Shih LY; Takaori-Kondo A; Makishima H; Ogawa S
    Blood Cancer Discov; 2022 Sep; 3(5):410-427. PubMed ID: 35839275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapeutics for Acute Erythroid Leukemia: Research, Present and Future.
    Liao Z; Li J; Wu J; Liu J; Sun S
    Curr Mol Med; 2021; 21(10):819-831. PubMed ID: 33475071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic subtyping and therapeutic targeting of acute erythroleukemia.
    Iacobucci I; Wen J; Meggendorfer M; Choi JK; Shi L; Pounds SB; Carmichael CL; Masih KE; Morris SM; Lindsley RC; Janke LJ; Alexander TB; Song G; Qu C; Li Y; Payne-Turner D; Tomizawa D; Kiyokawa N; Valentine M; Valentine V; Basso G; Locatelli F; Enemark EJ; Kham SKY; Yeoh AEJ; Ma X; Zhou X; Sioson E; Rusch M; Ries RE; Stieglitz E; Hunger SP; Wei AH; To LB; Lewis ID; D'Andrea RJ; Kile BT; Brown AL; Scott HS; Hahn CN; Marlton P; Pei D; Cheng C; Loh ML; Ebert BL; Meshinchi S; Haferlach T; Mullighan CG
    Nat Genet; 2019 Apr; 51(4):694-704. PubMed ID: 30926971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification.
    Hasserjian RP; Zuo Z; Garcia C; Tang G; Kasyan A; Luthra R; Abruzzo LV; Kantarjian HM; Medeiros LJ; Wang SA
    Blood; 2010 Mar; 115(10):1985-92. PubMed ID: 20040759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotypical profiling of myeloid neoplasms with erythroid predominance using mass cytometry (CyTOF).
    Maag AH; Swanton H; Kull M; Vegi NM; Feuring M
    Cytometry A; 2023 Jul; 103(7):551-562. PubMed ID: 36647792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute erythroid leukemia is enriched in NUP98 fusions: a report from the Children's Oncology Group.
    Chisholm KM; Heerema-McKenney AE; Choi JK; Smith J; Ries RE; Hirsch BA; Raimondi SC; Alonzo TA; Wang YC; Aplenc R; Sung L; Gamis AS; Meshinchi S; Kahwash SB
    Blood Adv; 2020 Dec; 4(23):6000-6008. PubMed ID: 33284945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute erythroleukemia: diagnosis and management.
    Santos FP; Bueso-Ramos CE; Ravandi F
    Expert Rev Hematol; 2010 Dec; 3(6):705-18. PubMed ID: 21091147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical characteristics and prognoses of 167 acute erythroleukemia patients].
    Cheng W; Sun A; Chen S; Qiu H; Yin J; Ping N; Wang Q; Wu D
    Zhonghua Xue Ye Xue Za Zhi; 2014 Nov; 35(11):970-3. PubMed ID: 25417871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute erythroid leukemia (AEL) can be separated into distinct prognostic subsets based on cytogenetic and molecular genetic characteristics.
    Grossmann V; Bacher U; Haferlach C; Schnittger S; Pötzinger F; Weissmann S; Roller A; Eder C; Fasan A; Zenger M; Staller M; Kern W; Kohlmann A; Haferlach T
    Leukemia; 2013 Sep; 27(9):1940-3. PubMed ID: 23648669
    [No Abstract]   [Full Text] [Related]  

  • 20. Pure erythroid leukemia following precursor B-cell lymphoblastic leukemia.
    Xu M; Finn LS; Tsuchiya KD; Thomson B; Pollard J; Rutledge J
    Pediatr Dev Pathol; 2012; 15(1):76-8. PubMed ID: 21877942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.